Monique P Curran
Overview
Explore the profile of Monique P Curran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curran M
Drugs Aging
. 2013 Apr;
30(6):447-58.
PMID: 23580320
Decitabine (Dacogen(®)) is a deoxynucleoside analogue of cytidine that selectively inhibits DNA methyltransferases. Decitabine administered at a dose of 20 mg/m(2) by a 1-h intravenous infusion for 5 consecutive days...
2.
Curran M
Drugs Aging
. 2012 Sep;
29(9):771-81.
PMID: 23018613
Tadalafil is a selective cyclic guanosine monophosphate-specific phosphodiesterase type 5 inhibitor. Once-daily tadalafil 5 mg was effective in treating the signs and symptoms of benign prostatic hyperplasia (BPH). In phase...
3.
Keating G, Duggan S, Curran M
CNS Drugs
. 2012 Jul;
26(9):787-90.
PMID: 22834568
Transdermal granisetron (Sancuso®) is effective in the prevention of nausea and vomiting in patients with cancer who are receiving moderately or highly emetogenic chemotherapy for 3-5 days. Transdermal granisetron is...
4.
Scott L, Carter N, Curran M
Paediatr Drugs
. 2012 Jun;
14(4):271-9.
PMID: 22702743
Live attenuated influenza vaccine (LAIV).[Fluenz™] has a convenient intranasal route of administration. In the EU, it is indicated for the prevention of influenza disease caused by the influenza virus strains...
5.
Curran M
Drugs
. 2011 Dec;
72(1):99-107.
PMID: 22191798
Crizotinib is an inhibitor of receptor tyrosine kinases (including anaplastic lymphoma kinase [ALK]). Oral crizotinib 250 mg twice daily was associated with clinically meaningful response rates in two noncomparative trials...
6.
Curran M
BioDrugs
. 2011 Dec;
26(1):53-9.
PMID: 22168385
Canakinumab is a recombinant, fully human, monoclonal, anti-human interleukin-1β (IL-1β) antibody that binds with high affinity and specificity to human IL-1β, preventing its interaction with IL-1 receptors. Canakinumab (150 mg...
7.
Curran M
Paediatr Drugs
. 2011 Dec;
14(1):51-60.
PMID: 22136276
Everolimus is an orally administered inhibitor of the mammalian target of rapamycin (mTOR). Everolimus (starting dosage 3.0 mg/m(2)) was associated with a significant reduction in the volume of the largest...
8.
Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report
Curran M
Drugs Aging
. 2011 Oct;
28(10):843-5.
PMID: 21970311
No abstract available.
9.
10.
Carter N, Curran M
Drugs
. 2011 Aug;
71(12):1591-622.
PMID: 21861544
Live attenuated influenza vaccine (LAIV) is an intranasally administered trivalent, seasonal influenza vaccine that contains three live influenza viruses (two type A [H1N1 and H3N2 subtypes] and one type B)....